Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis
Clinical trial NCT04292223 · COMPLETED
Trial details
- NCT number
- NCT04292223
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-10
- Primary completion
- 2022-04-26
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.